Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Total Debt (2016 - 2025)

STRATA Skin Sciences' Total Debt history spans 13 years, with the latest figure at $15.3 million for Q4 2025.

  • On a quarterly basis, Total Debt rose 1.03% to $15.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.3 million, a 1.03% increase, with the full-year FY2025 number at $15.3 million, up 1.03% from a year prior.
  • Total Debt hit $15.3 million in Q4 2025 for STRATA Skin Sciences, roughly flat from $15.3 million in the prior quarter.
  • Over the last five years, Total Debt for SSKN hit a ceiling of $15.3 million in Q4 2025 and a floor of $500000.0 in Q2 2021.
  • Historically, Total Debt has averaged $11.1 million across 5 years, with a median of $15.0 million in 2023.
  • Biggest five-year swings in Total Debt: crashed 80.22% in 2021 and later surged 1379.0% in 2022.
  • Tracing SSKN's Total Debt over 5 years: stood at $7.3 million in 2021, then increased by 2.15% to $7.5 million in 2022, then surged by 101.23% to $15.0 million in 2023, then rose by 0.98% to $15.2 million in 2024, then grew by 1.03% to $15.3 million in 2025.
  • Business Quant data shows Total Debt for SSKN at $15.3 million in Q4 2025, $15.3 million in Q3 2025, and $15.3 million in Q2 2025.